Sarrazin C - Search Results

1

Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection.

Mas Marques A, Mueller T, Welke J, Taube S, Sarrazin C, Wiese M, Halangk J, Witt H, Ahlenstiel G, Spengler U, Goebel U, Schott E, Weich V, Schlosser B, Wasmuth HE, Lammert F, Berg T, Schreier E. Mas Marques A, et al. Among authors: sarrazin c. Infect Genet Evol. 2009 Sep;9(5):847-52. doi: 10.1016/j.meegid.2009.05.002. Epub 2009 May 14. Infect Genet Evol. 2009. PMID: 19446659

2

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy.

Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S. Berg T, et al. Among authors: sarrazin c. Hepatology. 2003 Mar;37(3):600-9. doi: 10.1053/jhep.2003.50106. Hepatology. 2003. PMID: 12601358

3

Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.

Hofmann WP, Sarrazin C, Kronenberger B, Schönberger B, Bruch K, Zeuzem S. Hofmann WP, et al. Among authors: sarrazin c. J Infect Dis. 2003 Mar 15;187(6):982-7. doi: 10.1086/368221. Epub 2003 Mar 6. J Infect Dis. 2003. PMID: 12660945 Clinical Trial.

4

Apolipoprotein E4 allele is associated with poor treatment response in hepatitis C virus (HCV) genotype 1.

Mueller T, Gessner R, Sarrazin C, Graf C, Halangk J, Witt H, Köttgen E, Wiedenmann B, Berg T. Mueller T, et al. Among authors: sarrazin c. Hepatology. 2003 Dec;38(6):1592; author reply 1592-3. doi: 10.1016/j.hep.2003.09.042. Hepatology. 2003. PMID: 14647071 No abstract available.

5

Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.

Mueller T, Mas-Marques A, Sarrazin C, Wiese M, Halangk J, Witt H, Ahlenstiel G, Spengler U, Goebel U, Wiedenmann B, Schreier E, Berg T. Mueller T, et al. Among authors: sarrazin c. J Hepatol. 2004 Oct;41(4):652-8. doi: 10.1016/j.jhep.2004.06.021. J Hepatol. 2004. PMID: 15464247

6

GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection.

Sarrazin C, Berg T, Weich V, Mueller T, Frey UH, Zeuzem S, Gerken G, Roggendorf M, Siffert W. Sarrazin C, et al. J Hepatol. 2005 Sep;43(3):388-93. doi: 10.1016/j.jhep.2005.03.020. J Hepatol. 2005. PMID: 16019105

7

Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.

Sarrazin C, Mihm U, Herrmann E, Welsch C, Albrecht M, Sarrazin U, Traver S, Lengauer T, Zeuzem S. Sarrazin C, et al. Among authors: sarrazin u. J Infect Dis. 2005 Nov 15;192(10):1710-9. doi: 10.1086/497142. Epub 2005 Oct 14. J Infect Dis. 2005. PMID: 16235168

8

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.

Berg T, von Wagner M, Nasser S, Sarrazin C, Heintges T, Gerlach T, Buggisch P, Goeser T, Rasenack J, Pape GR, Schmidt WE, Kallinowski B, Klinker H, Spengler U, Martus P, Alshuth U, Zeuzem S. Berg T, et al. Among authors: sarrazin c. Gastroenterology. 2006 Apr;130(4):1086-97. doi: 10.1053/j.gastro.2006.02.015. Gastroenterology. 2006. PMID: 16618403 Clinical Trial.

9

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

van Bömmel F, Zöllner B, Sarrazin C, Spengler U, Hüppe D, Möller B, Feucht HH, Wiedenmann B, Berg T. van Bömmel F, et al. Among authors: sarrazin c. Hepatology. 2006 Aug;44(2):318-25. doi: 10.1002/hep.21253. Hepatology. 2006. PMID: 16871563

10

Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

Halangk J, Sarrazin C, Neumann K, Puhl G, Mueller T, Teuber G, Klinker H, Hinrichsen H, Buggisch P, Landt O, Weich V, Bergk A, Wiedenmann B, Neuhaus P, Berg T, Witt H. Halangk J, et al. Among authors: sarrazin c. J Hepatol. 2008 Sep;49(3):339-45. doi: 10.1016/j.jhep.2008.05.021. Epub 2008 Jun 23. J Hepatol. 2008. PMID: 18644651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page